Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
A phase 3 trial of Cytarabine, Daunorubicin, Etoposide and Clofarabine in Acute myeloid leukaemia, run by St. Jude Children's Research Hospital, completed.
Overview
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia is a phase 3 interventional study registered as NCT00703820 by St. Jude Children's Research Hospital, with 324 participants recorded, started 2008-08-04 and reaching its primary completion in 2017-03-30. Interventions recorded: Cytarabine, Daunorubicin, Etoposide, Clofarabine, CliniMACS. Conditions recorded: Acute Myeloid Leukemia.
Linked to the drug Clofarabine because the registry names it among its interventions and Acute myeloid leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialStudy Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT
Shares Clofarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialResponse-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Shares Daunorubicin, Cytarabine, Etoposide, Acute myeloid leukaemia and the tag pipeline.
- TrialA Safety and Efficacy Study of Eltrombopag in Subjects With AML
Shares Daunorubicin, Cytarabine and the tag pipeline.
- TrialStudy of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated
Shares Daunorubicin, Cytarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialCombination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Shares Clofarabine, Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
- TrialCombination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
Shares Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
- TrialTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
Shares Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
- TrialA Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Shares Daunorubicin, Cytarabine, Acute myeloid leukaemia and the tag pipeline.